Arteris
AIP · NASDAQ · Technology
$22.30
$0.07 (-0.31%) today
Market Cap
$1.10B
24h Volume
$38.2M
P/E Ratio
0.0
52w High
$48.59
52w Low
$9.68
Est. AI Revenue
45%
7-Day Sparkline (Static)
Company facts
Performance
About Arteris
Arteris licenses semiconductor interconnect IP: the network-on-chip technology that moves data between the processing blocks inside a system-on-chip. Chipmakers pay license fees when they adopt the technology during design, then royalties on each chip shipped, a model similar to Arm applied at the interconnect level of the chip.
FlexNoC and the cache-coherent Ncore are its core interconnect products, FlexGen applies AI to automate network-on-chip design, and Magillem manages SoC integration data. AI chips are its stated primary growth driver: accelerators and AI SoCs must move enormous volumes of data between compute blocks and memory, which makes the on-chip network a critical piece of every new design.
Founded in 2003 and headquartered in Campbell, California, Arteris employs about 360 people and trades on the NASDAQ.
Arteris in the AI buildout
Arteris sits in the Semiconductors layer as an IP licensor, filling the same slot as Arm, CEVA, and Rambus in the Supercycle universe. Every AI accelerator needs an on-chip network to shuttle data between compute tiles and memory controllers, and licensing that plumbing is faster than designing it from scratch. Arteris monetizes the AI silicon design wave itself: more companies designing custom AI chips means more licenses today and royalty streams as those chips reach volume production.
AIP is tracked in Semiconductors, rated Strategic on the AI Exposure leaderboard.
By the numbers
52-week range
AIP trades at $22.30, 32% of the way up its 52-week range of $9.68 to $48.59.
Market cap
Market capitalization is $1.10B, with an AI Exposure Score of 68 out of 100.
Next earnings
Arteris is next expected to report earnings on November 3, 2026.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does Arteris do?
Arteris licenses network-on-chip interconnect IP, the technology that routes data between processing blocks inside a system-on-chip. Chip designers pay license fees to use products like FlexNoC and Ncore, then per-unit royalties once their chips ship.
How is Arteris exposed to AI?
Supercycle rates Arteris as Strategic with an AI Exposure Score of 68 out of 100. AI-driven chip design starts are its primary growth driver, and a large share of its licensing pipeline is AI accelerators and AI-enabled SoCs.
What are Arteris' main products?
FlexNoC is its flagship non-coherent interconnect, Ncore adds cache coherency for complex multiprocessor designs, FlexGen uses AI to automate interconnect generation, and Magillem handles SoC integration and design data management for large chip projects.
Who leads Arteris?
Charles Janac has led Arteris as chief executive since its early years, guiding it from a French-rooted startup to a NASDAQ-listed IP licensor whose interconnect technology appears in chips across AI, automotive, and consumer markets.
Is AIP a pure play AI stock?
Not quite. Arteris is a Strategic tier stock, near the top of that band. Its interconnect IP also serves automotive and consumer chips, but AI designs are the fastest-growing part of its pipeline and the core of its growth story.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.
Related reading
- How to follow smart money with 13F filings · 13F filings show what Buffett, Druckenmiller and 20 other managers own each quarter. How to read one, what it hides, and how to use it without copying blind.
- How to track congress stock trades, step by step · Congress must disclose every stock trade over $1,000 within 45 days. Where the filings live, how to read one line by line, and what the ranges and dates hide.
- What are AI infrastructure stocks? The 12 layers, explained · AI infrastructure stocks are the companies paid to build AI compute: chips, memory, networking, data centers, cooling and power. The 12 layers and the catch.